Hydrogen sulfide protects H9c2 cardiomyoblasts against [H.sub.2][O.sub.2]-induced apoptosis.
Reactive oxygen species (ROS) are highly reactive chemical species from cellular metabolism involving oxygen consumption (1). In normal tissues, approximately 5% of the consumed oxygen molecules are transformed into ROS (2). These ROS can initiate chain reactions in tissues, leading to irreversible damage in proteins, lipids, and nucleic acids (1). ROS play an essential role in regulating cell activities, such as gene expression, cell growth, and cell death (3). ROS can be detoxified by endogenous enzymes or free radical scavengers. However, the imbalance between antioxidants and oxidants leads to overproduction of ROS. This effect is associated with many multifactorial diseases, such as cardiovascular disorders (4,5). Global ischemia and reperfusion have been associated with the upregulation of ROS in cardiomyocytes (e.g., hydrogen peroxide [[H.sub.2][O.sub.2]]), resulting in oxidative stress injuries (6). [H.sub.2][O.sub.2] may cause apoptosis in cardiomyocytes by activating the intrinsic apoptotic pathways. Therefore, [H.sub.2][O.sub.2] is often utilized to establish an in vitro model for ischemia and subsequent reperfusion (I/R) injury (4,5).
Hydrogen sulfide ([H.sub.2]S) is predominantly synthesized from L-cysteine via cystathionine [gamma]-lyase in the heart and vasculature. [H.sub.2]S has drawn great scientific interest regarding myocardial protection. [H.sub.2]S possesses almost all the beneficial cardiovascular effects similar to another well-characterized gasotransmitter, nitric oxide (NO) (7). Moreover, [H.sub.2]S acts as a ROS scavenger without producing deleterious ROS, which is typically seen in NO. [H.sub.2]S is rapidly emerging as a novel lipophilic cytoprotective signaling molecule with potent antioxidant, anti-inflammatory, and anti-apoptotic features (8,9). Our previous in vivo study revealed that the exogenous [H.sub.2]S donor, sodium hydrosulfide (NaHS), has potent anti-inflammatory effects in the heart damaged by acute myocardial infarction, which may be partially due to the limited [CD11b.sup.+] [Gr-1.sup.+] myeloid cells (10).
Although we have discovered the physiological and cardioprotective effects of [H.sub.2]S, the signaling mechanisms that mediate these effects have not been thoroughly evaluated. This study aimed to elucidate the mechanisms by which [H.sub.2]S prevents apoptosis of cardiomyocytes. In particular, we studied the mitochondrial pathway in response to [H.sub.2][O.sub.2]-induced oxidative stress using an in vitro model that mimicked ischemia-reperfusion injuries.
Material and Methods
[H.sub.2]S was administered in the form of sodium hydrosulfide (NaHS) (Sigma-Aldrich, Cat. No.161527, USA). NaHS was freshly prepared in normal saline (0.9%) to the desired concentration before administration.
H9c2 cells (rat cardiomyoblasts) were obtained from the Cell Bank of the Chinese Academy of Sciences (China), and grown at a density of [10.sup.5] cells/[cm.sup.2] as a monolayer. H9c2 cells were cultured in Dulbecco's modified Eagle medium (GIBCO, Cat. No. 11960-077, USA) supplemented with 10% v/v fetal bovine serum, 2 mM glutamine, 1% nonessential amino acids, 100 IU penicillin, and 100 [micro]g/mL streptomycin under an atmosphere of 5% C[O.sub.2] saturated with water vapor at 37[degrees]C. The medium was replaced by fresh medium every two days. Subculture was done when the plates were more than 90% confluency.
Hydrogen peroxide treatment
To induce oxidative stress in H9c2 cells, the cells were cultured in serum-free medium containing 100 [micro]M [H.sub.2][O.sub.2] for 24 h with or without a 30 min pre-treatment of 100 [micro]M NaHS. [H.sub.2][O.sub.2] and NaHS were freshly prepared before each experiment. Control groups were treated with both [H.sub.2][O.sub.2] and NaHS simultaneously.
An annexin V apoptosis detection kit (BD Biosciences, Cat. No. 556547, USA) was utilized to measure apoptosis of H2c9 cells following the manufacturer's instruction. After treatments, cells were washed twice with cold PBS, trypsinized, and then resuspended in the binding buffer at a concentration of 1 x [10.sup.6] cells/mL. A 100 [micro]L-aliquot of the cell suspension (1 x [10.sup.5] cells) was then incubated with fluorescein isothiocyanate (FITC)-annexin V and propidium iodide for 15 min at room temperature in the dark. Apoptotic rate was analyzed using flow cytometry within 1 h.
Measurement of ROS production
The presence of intracellular ROS was detected using dihydroethidium (DHE, Sigma, Cat. No. D7008, USA), a sensitive fluorescent dye. According to the manufacturer's instructions, sub-confluent cells were pre-treated with or without 100 [micro]M NaHS for 30 min, and then further incubated with 100 [micro]M [H.sub.2][O.sub.2] for 24 h. Cells were then washed with PBS and incubated with 5 [micro]M DHE at 37[degrees]C for 30 min. Fluorescence was captured with a fluorescent microscope, and the signal intensity was reported as a percentage of the control group.
Measurement of mitochondrial membrane potential ([[psi].sub.m])
Changes in the [[psi].sub.m] were detected using a mitochondria-specific cationic dye, JC-1 (Life Technologies, Cat. No. T3168, USA). JC-1 is a lipophilic cation that can selectively enter into mitochondria. H9c2 cells with or without [H.sub.2][O.sub.2] treatment were incubated with 10 [micro]g/mL JC-1 at 37[degrees]C in the dark for 10 min. The loading solution was then replaced with fresh medium, and the fluorescent signal was captured and analyzed using the fluorescence microscopy. Red emission indicates membrane potential-dependent JC-1 aggregates in mitochondria. Green fluorescence reflects the monomeric form of JC-1 appearing in the cytoplasm after mitochondrial membrane depolarization. Consequently, mitochondrial depolarization is indicated by a decrease in the red/green fluorescence intensity ratio.
Western blot analysis
Western blot analysis was performed as previously described (11). Total protein lysates were collected for the standard immunoblot analysis. Protein concentrations were determined by a BCA protein assay. Aliquots of protein lysates (30 [micro]g/lane) were loaded into sodium dodecyl sulfidepolyacrylamide gels (SDS-PAGE) and transferred to the PVDF membrane. The membrane was blocked and incubated with Bcl-2, Bax, and activated-caspase 3 p17 primary antibodies overnight at 4[degrees]C. Bcl-2 and Bax antibodies were purchased from Cell Signaling Technology (USA) (Bcl-2 Cat. No. 3498; Bax Cat. No. 14796), and activated-caspase 3 p17 antibody was from Bioworld (Cat. No. BS7004, USA). Blots were washed with TBST (Sigma-Aldrich), followed by incubation with corresponding horseradish peroxidase-conjugated secondary antibodies (Jackson Laboratory, USA). Lastly, the blots were visualized with enhanced chemiluminescence and were quantified by densitometry.
Data are reported as means [+ or -] SE. Different groups were compared using one-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls post hoc test. Comparison between two groups was assessed by t-test. P < 0.05 was considered statistically significant.
[H.sub.2]S reduced [H.sub.2][O.sub.2]-induced apoptosis
To determine whether [H.sub.2]S affected [H.sub.2][O.sub.2]-induced apoptosis in H2c9 cells, we performed annexin V & PI assays. Flow cytometry was then utilized to evaluate the apoptotic rate (Figure 1A). Compared to the control group, [H.sub.2][O.sub.2] significantly induced cell apoptosis, but the presence of [H.sub.2]S rescued [H.sub.2][O.sub.2] cytotoxicity, and increased cell viability (Figure 1B).
[H.sub.2]S protected H9c2 cells from oxidative stress
Oxidative stress leads to detrimental changes in the cell signaling process. To determine whether [H.sub.2]S has any effect on ROS activity under oxidative stress, we examined total ROS levels using DHE. Compared to the control group, H9c2 cells with [H.sub.2][O.sub.2] treatment showed an enhancement of fluorescence intensity by approximately six-fold. However, pre-treatment with [H.sub.2]S demonstrated a significant rescue effect (50.2% reduction of the fluorescence intensity) (Figure 2).
[H.sub.2]S prevented the loss of mitochondrial membrane potential ([[psi].sub.m])
Mitochondrial function is highly sensitive to oxidative damages. In this study, we applied the fluorescent dye JC-1 to investigate whether [H.sub.2]S protected the physical functions of mitochondria from [H.sub.2][O.sub.2]-induced cell stress in the cell model. In the control group, H9c2 cells exhibited numerous brightly stained mitochondria that emitted orange fluorescence (Figure 3A). After treating with [H.sub.2][O.sub.2] for 24 h, H9c2 cells demonstrated fewer and less stained mitochondria (Figure 3B). [H.sub.2]S pre-treatment, on the other hand, prevented [H.sub.2][O.sub.2]-induced loss of mitochondrial membrane potential.
[H.sub.2]S regulated the expression of apoptosis-related proteins
Compared to the expression levels of [H.sub.2][O.sub.2]-treated H9c2 cells, the protein expression level of Bax was significantly reduced, while Bcl-2 expression was increased in the NaHS-treated cells (Figure 4A). Consequently, compared with the [H.sub.2][O.sub.2] group, the ratio of Bcl-2 to Bax was higher in the NaHS + [H.sub.2][O.sub.2] group (Figure 4B-D). The expression level of activated caspase 3, another apoptotic marker, was also examined (Figure 4E). The results suggested that [H.sub.2][O.sub.2] enhanced apoptosis in H9c2 cells, while the NaHS treatments decreased [H.sub.2][O.sub.2]-induced apoptosis.
As a gaseous signaling molecule, [H.sub.2]S can freely diffuse across cell membranes and activate various cellular targets. This distinct feature makes [H.sub.2]S an attractive pharmacological agent to treat cardiovascular diseases. Previous studies have demonstrated a compelling cardioprotective effect of [H.sub.2]S in rat and mouse models (12-14). We have shown that [H.sub.2]S pre-treatment efficiently protected human ventricular fibroblasts from [H.sub.2][O.sub.2]-induced endoplasmic reticulum (ER) stress and prevented the activation of caspase cascade (15). In the current study, we showed that [H.sub.2]S protected H9c2 cardioblasts from [H.sub.2][O.sub.2]-induced oxidative stress. [H.sub.2]S regulated the cell cycle, decreased apoptotic cells, and preserved mitochondrial membrane potential [[psi].sub.m] that is essential for ATP production and homeostasis. [H.sub.2]S also upregulated Bcl-2/Bax ratio, suggesting its critical role in the anti-apoptotic mechanisms. Both studies indicated the holistic role of [H.sub.2]S in protecting the cardiovascular system.
Oxidative stress is the imbalance between ROS production and detoxification. This imbalance impairs the capacity to repair the damages caused by reactive intermediates. Moreover, imbalance in oxidative states may lead to the generation of peroxides and free radicals, which in turn damage proteins, lipids, and DNA (1). Oxidative damage from [H.sub.2][O.sub.2] contributes to heart failure and tissue damages (16). The [H.sub.2][O.sub.2] molecule plays an essential role in the progression of oxidative stress and cardiac pathologies (17,18). In addition, excessive ROS damages mitochondria, opens its permeability transition pore (PTP), and thus induces mitochondrial permeability transition. These alterations cause mitochondrial depolarization and outer membrane rupture, leading to cell apoptosis or death (19,20). Apoptosis that occurs in the clinical setting (e.g., open-heart surgery under cardiopulmonary bypass) is induced by various conditions and agents, including ROS, NO, calcium, and pressure overload, mechanical stress, tumor necrosis factor, and angiotensin II. Apoptosis has also been shown to play a pivotal role in the pathogenesis of ischemia/reperfusion (21).
Endogenous gaseous signaling mediators, such as [H.sub.2]S, are formed in mammalian cells and tissues. [H.sub.2]S may easily react with certain compounds, especially with reactive oxygen and nitrogen species, such as superoxide radical anion ([O.sub.2-]), [H.sub.2][O.sub.2], peroxynitrite (ONOO-), and hypochlorite (CIO-) (22-24). In the current study, we demonstrated that [H.sub.2][O.sub.2] induced ROS production and decreased mitochondrial membrane potential, suggesting an impairment of mitochondrial functions. [H.sub.2]S treatment, however, attenuated the ROS production, restored mitochondrial membrane potential, and decreased cardiomyocyte apoptosis. [H.sub.2]S may protect mitochondrial function via multiple pathways, such as activating AMPK in cardiomyocytes (25).
Previous studies showed that Bcl-2 family is upregulated during the opening of PTP (19,20). PEP-1-CAT, a fusion protein of anti-microbial peptide and antioxidant enzyme, protects cardiomyocyte from hypoxia/reoxygenation-induced injuries. PEP-1-CAT blocks Bcl-2/Bax/mitochondrial apoptotic pathway by inhibiting p38 MAPK while activating the PI3K/Akt and Erk1/2 signaling pathways (26). Here, we also found [H.sub.2]S regulated the Bcl-2/Bax/ caspase-3 signaling pathway in the rat cardiomyoblasts. The functions of Bcl-2 (anti-apoptosis) and Bax (proapoptosis) proteins are in opposition of the apoptotic pathway. When the apoptotic signal is present, caspase 3 (32 kD) will be cleaved and present as an active form (17 kD) to induce cell apoptosis (27). In our study, [H.sub.2][O.sub.2] treatment led to a shift in favor of the pro-apoptotic protein, Bax, as well as upregulated the downstream effector, caspase 3. On the other hand, [H.sub.2]S rescued this apoptotic event and downregulated the level of caspase 3, demonstrating a cytoprotective effect in the rat cardiomyoblasts.
In conclusion, we demonstrated that NaHS has potent anti-apoptotic effects in cardiomyoblasts with [H.sub.2][O.sub.2]-induced injuries. The anti-apoptotic function may be partially due to blocking ROS production in mitochondria, maintaining mitochondrial membrane integrity, and inhibiting activation of the Bcl-2/Bax apoptotic pathway. The current study suggested that [H.sub.2]S may serve as an effective therapeutic option for treating ischemia-reperfusion injuries.
This study was supported by the National Nature Science Foundation of China (No. 81500237 and 81701891) and Special Foundation for Knowledge Innovation of Hubei Province (Nature Science Foundation) (No. 2017CFB563).
(1.) Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am JMed2000; 109: 315-323, doi: 10.1016/S0002-9343(00) 00467-8.
(2.) McCord JM. Free radicals and myocardial ischemia: overview and outlook. Free Radio Biol Med 1988; 4: 9-14, doi: 10.1016/0891-5849(88)90005-6.
(3.) Radomska-Lesniewska DM, Hevelke A, Skopinski P, Balan B, Jozwiak J, Rokicki D, et al. Reactive oxygen species and synthetic antioxidants as angiogenesis modulators: clinical implications. Pharmacol Rep 2016; 68: 462-471, doi: 10.1016/ j.pharep.2015.10.002.
(4.) Griendling KK, Touyz RM, Zweier JL, Dikalov S, Chilian W, Chen YR, et al. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the american heart association. Circ Res 2016; 119: e39-e75, doi: 10.1161/RES.0000000000000110.
(5.) Chen K, Keaney JF Jr. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep 2012; 14: 476-483, doi: 10.1007/s11883012-0266-8.
(6.) Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem 2007; 14: 1539-1549, doi: 10.2174/092986707780831078.
(7.) Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S, et al. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2012; 32: 1093-1130, doi: 10.1002/ med.20234.
(8.) Lefer DJ. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci USA 2007; 104: 17907-17908, doi: 10.1073/pnas.0709010104.
(9.) Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009; 105: 365-374, doi: 10.1161/CIRCRESAHA. 109.199919.
(10.) Zhang Y, Li H, Zhao G, Sun A, Zong NC, Li Z, et al. Hydrogen sulfide attenuates the recruitment of CD11b(+) Gr-1(+) myeloid cells and regulates Bax/Bcl-2 signaling in myocardial ischemia injury. Sci Rep 2014; 4: 4774, doi: 10.1038/srep04774.
(11.) Zhang Y, Wang J, Li H, Yuan L, Wang L, Wu B, et al. Hydrogen sulfide suppresses transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts. Sci China Life Sci2015; 58: 1126-1134, doi: 10.1007/s11427-015-4904-6.
(12.) Xie X, Sun A, Zhu W, Huang Z, Hu X, Jia J, et al. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med 2012; 226: 29-36, doi: 10.1620/tjem. 226.29.
(13.) Liu Z, Han Y, Li L, Lu H, Meng G, Li X, et al. Hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E mice. British J Pharmacol 2013; 169: 1795-1809, doi: 10.1111/bph.12246.
(14.) Ma SF, Luo Y, Ding YJ, Chen Y, Pu SX, Wu HJ, et al. Hydrogen sulfide targets the cys320/cys529 motif in kv4.2 to inhibit the ito potassium channels in cardiomyocytes and regularizes fatal arrhythmia in myocardial infarction. Antioxid Redox Signal 2015; 23: 129-147, doi: 10.1089/ars.2014. 6094.
(15.) Feng A, Ling C, Xin Duo L, Bing W, San Wu W, Yu Z, et al. Hydrogen sulfide protects human cardiac fibroblasts against [H.sub.2][O.sub.2]-induced injury through regulating autophagy-related proteins. Cell Transplant2018; 27: 1222-1234, doi: 10.1177/ 0963689718779361.
(16.) Seo YJ, Lee JW, Lee EH, Lee HK, Kim HW, Kim YH. Role of glutathione in the adaptive tolerance to H2O2. Free Rad Biol Med 2004; 37: 1272-1281, doi: 10.1016/j.freeradbiomed. 2004.07.012.
(17.) Slezak J, Tribulova N, Pristacova J, Uhrik B, Thomas T, Khaper N, et al. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol 1995; 147: 772-781.
(18.) Liu Y, Bubolz AH, Mendoza S, Zhang DX, Gutterman DD. H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res 2011; 108: 566-573, doi: 10.1161/CIRCRESAHA.110.237636.
(19.) Rasola A, Bernardi P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 2007; 12: 815-833, doi: 10.1007/ s10495-007-0723-y.
(20.) Rannikko EH, Vesterager LB, Shaik JH, Weber SS, Cornejo Castro EM, Fog K, et al. Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion. J Neurochem 2013; 125: 314-327, doi: 10.1111/jnc.12126.
(21.) Shan D, Marchase RB, Chatham JC. Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes. Am J Physiol Cell Physiol 2008; 294: C833-C841, doi: 10.1152/ ajpcell.00313.2007.
(22.) Mitsuhashi H, Yamashita S, Ikeuchi H, Kuroiwa T, Kaneko Y, Hiromura K, et al. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 2005; 24: 529-534, doi: 10.1097/01.shk.0000183393.832 72.de.
(23.) Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 2004; 90: 765-768, doi: 10.1111/j.1471-4159.2004. 02617.x.
(24.) Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem Biophys Res Commun 2005; 326: 794-798, doi: 10.1016/j.bbrc.2004.11.110.
(25.) Wagner F, Asfar P, Calzia E, Radermacher P, Szabo C. Bench-to-bedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care. Crit Care 2009; 13: 213, doi: 10.1186/cc7700.
(26.) Zhang L, Wei S, Tang JM, Guo LY, Zheng F, Yang JY, et al. PEP-1-CAT protects hypoxia/reoxygenation-induced cardiomyocyte apoptosis through multiple sigaling pathways. J Transl Med 2013; 11: 113, doi: 10.1186/1479-587611-113.
(27.) Wang X, Wang Q, Guo W, Zhu YZ. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. BiosciRep 2011; 31: 87-98, doi: 10.1042/BSR20100003.
You En Zhang  *, Guang Qing Huang  *, Bing Wu , Xin Duo Lin , Wen Zi Yang , Zun Yu Ke  and Jie Liu (iD) 
 Department of Cardiology, Institute of Clinical Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, China
 Department of Intensive Care Unit, Renmin Hospital, Hubei University of Medicine, Shiyan, China
 Department of Neurology, Renmin Hospital, Hubei University of Medicine, Shiyan, China
Correspondence: Zun Yu Ke: <email@example.com> | Jie Liu: <firstname.lastname@example.org>
* These authors contributed equally to this work
Received September 11, 2018 | Accepted December 6, 2018
Caption: Figure 1. Hydrogen sulfide ([H.sub.2]S) reduced [H.sub.2][O.sub.2]-induced H9c2 apoptosis. A, Cell death analysis of treated cells was performed by flow cytometry with annexin V/PI double staining. Representative quantitative analysis is shown in B. Data are reported as means [+ or -] SE (n=6). * P < 0.05, ** P < 0.01 vs control; # P < 0.05, ## P < 0.01 vs NaHS; & p < 0.01 vs [H.sub.2][O.sub.2] (ANOVA followed by Student-Newman-Keuls post hoc test).
Caption: Figure 2. Hydrogen sulfide ([H.sub.2]S) protected H9c2 cells against [H.sub.2][O.sub.2]-induced oxidative stress (A). Intracellular superoxide anion production was detected with dihydroethidium and observed by fluorescent microscopy (B). The fluorescent signal was measured and quantified. Data are reported as means [+ or -] SE (n=6). * P < 0.01 vs control; # P < 0.01 vs NaHS; & P < 0.01 vs [H.sub.2][O.sub.2] (ANOVA followed by Student-Newman-Keuls post hoc test). ROS: reactive oxygen species.
Caption: Figure 3. Hydrogen sulfide ([H.sub.2]S) prevented the loss of mitochondrial membrane potential ([[psi].sub.m]) (A). The ([[psi].sub.m] loss was determined by the lipophilic cationic probe JC-1. Red signal indicates JC-1 in mitochondria and green signal indicates cytosolic JC-1. Magnification x 400; bar: 50 [micro]m. B, Quantitative analysis of membrane potential. Data are reported as means [+ or -] SE (n=6). * P < 0.01 vs control; # P < 0.01 vs NaHS; & P < 0.05 vs [H.sub.2][O.sub.2] (ANOVA followed by the Student-Newman-Keuls post hoc test).
Caption: Figure 4. Hydrogen sulfide ([H.sub.2]S) regulated the expression of apoptosis-related proteins. A, Representative immunoblots showing the expression of Bax, Bcl-2, and activated caspase 3 p17 in the H9c2 cells. Bax (B) and Bcl-2 (C) expression normalized to GAPDH (n=6). D, Densitometric analysis of the ratio of Bcl-2 to Bax. E, Activated caspase 3 p17 expression normalized to GAPDH. Data are reported as means [+ or -] SE (n=6) (ANOVA followed by Student-Newman-Keuls post hoc test). NS: not significant.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Zhang, You En; Huang, Guang Qing; Wu, Bing; Lin, Xin Duo; Yang, Wen Zi; Ke, Zun Yu; Liu, Jie|
|Publication:||Brazilian Journal of Medical and Biological Research|
|Date:||Apr 1, 2019|
|Previous Article:||Differential expression of microRNA-411 and 376c is associated with hypertension in pregnancy.|
|Next Article:||Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells.|